SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-02-000026
Filing Date
2002-02-04
Accepted
2002-02-04 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED ANNUAL 13G vphm2001.txt SC 13G 7246
  Complete submission text file 0000053417-02-000026.txt   9263
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Subject) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48239 | Film No.: 02526131
SIC: 2834 Pharmaceutical Preparations